Transfusion reactions: prevention, diagnosis, and treatment

Blood transfusion is one of the most common procedures in patients in hospital so it is imperative that clinicians are knowledgeable about appropriate blood product administration, as well as the signs, symptoms, and management of transfusion reactions. In this Review, we, an international panel, provide a synopsis of the pathophysiology, treatment, and management of each diagnostic category of transfusion reaction using evidence-based recommendations whenever available.

[1]  A. Tobian,et al.  Hypotensive transfusion reactions in the era of prestorage leukoreduction , 2015, Transfusion.

[2]  P. Weinbreck,et al.  Residual risk and retrospective analysis of transfusion‐transmitted bacterial infection reported by the French National Hemovigilance Network from 2000 to 2008 , 2015, Transfusion.

[3]  A. Meikle,et al.  Management of prolonged QT interval during a massive transfusion: calcium, magnesium or both? , 2000, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[4]  A. Piccin,et al.  Transfusion‐associated circulatory overload in Ireland: a review of cases reported to the National Haemovigilance Office 2000 to 2010 , 2015, Transfusion.

[5]  S. Dzik,et al.  Hyperhemolysis syndrome in anemia of chronic disease , 2005, Transfusion.

[6]  J. Henry,et al.  Febrile nonhemolytic transfusion reactions. Management by premedication and cost implications in adult patients. , 2004, Archives of pathology & laboratory medicine.

[7]  N. Heddle,et al.  Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storage , 2004, Transfusion.

[8]  K. Hanschmann,et al.  Transfusion-Transmitted Bacterial Infections – Haemovigilance Data of German Blood Establishments (1997–2010) , 2011, Transfusion Medicine and Hemotherapy.

[9]  O. Castro,et al.  Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease , 1990 .

[10]  S. Buck,et al.  The differentiation of delayed serologic and delayed hemolytic transfusion reactions: incidence, long‐term serologic findings, and clinical significance , 1990, Transfusion.

[11]  N. Juffermans,et al.  Transfusion-related acute lung injury: a clinical review , 2013, The Lancet.

[12]  B. Molini,et al.  Photochemical treatment of platelet concentrates with amotosalen and long‐wavelength ultraviolet light inactivates a broad spectrum of pathogenic bacteria , 2004, Transfusion.

[13]  S. Sowemimo-Coker,et al.  Experimental prestorage filtration removes antibodies and decreases lipids in RBC supernatants mitigating TRALI in vivo. , 2014, Blood.

[14]  E. Heitmiller,et al.  Transfusion‐associated hyperkalemic cardiac arrest in pediatric patients receiving massive transfusion , 2014, Transfusion.

[15]  G. Garratty.  WHAT DO WE MEAN BY “HYPERHAEMOLYSIS” AND WHAT IS THE CAUSE? , 2012, Transfusion medicine.

[16]  J. Winters,et al.  Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions , 2010, Transfusion.

[17]  M. Delaney,et al.  Risk of Extracorporeal Life Support Circuit-Related Hyperkalemia Is Reduced by Prebypass Ultrafiltration , 2013, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[18]  Wendell,et al.  Transfusion and Alloimmunization in Sickle Cell Disease , 2003 .

[19]  N. Heddle.  Pathophysiology of febrile nonhemolytic transfusion reactions. , 1999, Current opinion in hematology.

[20]  B. Zavizion,et al.  Inactivation of Gram‐negative and Gram‐positive bacteria in red cell concentrates using INACTINE PEN110 chemistry , 2004, Vox sanguinis.

[21]  E. Massey,et al.  Guideline on the investigation and management of acute transfusion reactions Prepared by the BCSH Blood Transfusion Task Force , 2012, British journal of haematology.

[22]  E. Vamvakas,et al.  The differentiation of delayed hemolytic and delayed serologic transfusion reactions: incidence and predictors of hemolysis , 1995, Transfusion.

[23]  D. Triulzi,et al.  Transfusion‐associated circulatory overload after plasma transfusion , 2012, Transfusion.

[24]  H. Fredlund,et al.  A RETROSPECTIVE STUDY OF ACUTE PLASMA EXCHANGE IN SEVERE INTRAVASCULAR HEMOLYSIS , 1989, European journal of haematology.

[25]  K. Nibu,et al.  Potassium‐adsorption filter for RBC transfusion: a Phase III clinical trial , 2000, Transfusion.

[26]  S. G. Williamson,et al.  Histamine antagonists in the treatment of acute allergic reactions. , 1992, Annals of emergency medicine.

[27]  M. Edwards,et al.  Trial , 2004, The Lancet.

[28]  R. Adams,et al.  Prospective RBC phenotype matching in a stroke‐prevention trial in sickle cell anemia: a multicenter transfusion trial , 2001, Transfusion.

[29]  N. Dunbar,et al.  Safety of platelet transfusion: past, present and future , 2014, Vox sanguinis.

[30]  M. El-Dib,et al.  Red blood cell transfusion, feeding and necrotizing enterocolitis in preterm infants , 2011, Journal of Perinatology.

[31]  J F Chapman,et al.  Blood inventory management , 2004, Vox sanguinis.

[32]  D. Triulzi,et al.  A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. , 2014, American journal of clinical pathology.

[33]  Laurence Klotz.  Reactions , 2002, The Lancet.

[34]  G. Guyatt,et al.  Grading strength of recommendations and quality of evidence in clinical guidelines: report from an american college of chest physicians task force. , 2006, Chest.

[35]  J. Zupancic,et al.  Do transfusions cause necrotizing enterocolitis? The complementary role of randomized trials and observational studies. , 2012, Seminars in perinatology.

[36]  C. Mueller-Eckhardt,et al.  High-dose IgG for post-transfusion purpura-revisited , 1988, Blut.

[37]  Adel Mohamed,et al.  Transfusion Associated Necrotizing Enterocolitis: A Meta-analysis of Observational Data , 2012, Pediatrics.

[38]  D. Sesok-Pizzini,et al.  Hyperkalemic cardiac arrest in pediatric patients undergoing massive transfusion: unplanned emergencies , 2014, Transfusion.

[39]  R. W. Patterson,et al.  Acute clinical hypocalcemic myocardial depression during rapid blood transfusion and postoperative hemodialysis: a preventable complication. , 1976, The Journal of thoracic and cardiovascular surgery.

[40]  J. Gornbein,et al.  Nearly two decades using the check-type to prevent ABO incompatible transfusions: one institution's experience. , 2006, American journal of clinical pathology.

[41]  A. Casbard,et al.  The impact of universal leukodepletion of the blood supply on hemovigilance reports of posttransfusion purpura and transfusion‐associated graft‐versus‐host disease , 2007, Transfusion.

[42]  R. Lin,et al.  Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonists. , 2000, Annals of emergency medicine.

[43]  H. Abe,et al.  Bradykinin generation during filtration of platelet concentrates with a white cell‐reduction filter , 1995, Transfusion.

[44]  Ritesh Patel,et al.  Acute Hypotensive Transfusion Reaction With Concomitant Use of Angiotensin-Converting Enzyme Inhibitors: A Case Report and Review of the Literature , 2012, American journal of therapeutics.

[45]  M. Delaney,et al.  The immunohematologic and patient safety benefits of a centralized transfusion database , 2013, Transfusion.

[46]  L. Kanz,et al.  Successful use of eculizumab for treatment of an acute hemolytic reaction after ABO‐incompatible red blood cell transfusion , 2015, Transfusion.

[47]  C. Westhoff,et al.  High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. , 2013, Blood.

[48]  C. Lockwood,et al.  Effectiveness of strategies for the management and/or prevention of hypothermia within the adult perioperative environment. , 2011, International journal of evidence-based healthcare.

[49]  R. Strauss.  RBC storage and avoiding hyperkalemia from transfusions to neonates & infants. , 2010, Transfusion.

[50]  C. Tormey,et al.  Limiting the extent of a delayed hemolytic transfusion reaction with automated red blood cell exchange. , 2013, Archives of pathology & laboratory medicine.

[51]  Edward Abraham,et al.  Transfusion-related acute lung injury: definition and review. , 2005, Critical care medicine.

[52]  C. Pui,et al.  Premedication with acetaminophen or diphenhydramine for transfusion with leucoreduced blood products in children , 2005, British journal of haematology.

[53]  A. Désormeaux,et al.  Acute hypotensive transfusion reaction during liver transplantation in a patient on angiotensin converting enzyme inhibitors from low aminopeptidase P activity , 2008, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[54]  M. Goldman,et al.  How do I investigate septic transfusion reactions and blood donors with culture‐positive platelet donations? , 2011, Transfusion.

[55]  K. Anderson,et al.  Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis. , 1990, The New England journal of medicine.

[56]  W. Dzik,et al.  Citrate toxicity during massive blood transfusion. , 1988, Transfusion medicine reviews.

[57]  Edmond Lee,et al.  Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. , 2010, Transfusion medicine reviews.

[58]  K. Leslie,et al.  Perioperative hypothermia in the high-risk surgical patient. , 2003, Best practice & research. Clinical anaesthesiology.

[59]  P. Bierling,et al.  The use of rituximab to prevent severe delayed haemolytic transfusion reaction in immunized patients with sickle cell disease , 2015, Vox sanguinis.

[60]  J. Scott,et al.  Delayed hemolytic transfusion reaction/hyperhemolysis syndrome in children with sickle cell disease. , 2003, Pediatrics.

[61]  M. Elliott,et al.  Critical care: the eight vital signs of patient monitoring. , 2012, British journal of nursing.

[62]  P. Sharek,et al.  Implementation of a two‐specimen requirement for verification of ABO/Rh for blood transfusion , 2009, Transfusion.

[63]  Howland Ws,et al.  Cold or warmed blood for massive transfusions , 1963 .

[64]  Shruti Gupta,et al.  Hyperhemolysis syndrome in a patient without a hemoglobinopathy, unresponsive to treatment with eculizumab , 2015, Transfusion.

[65]  A. Tobian,et al.  Prevention of allergic transfusion reactions to platelets and red blood cells through plasma reduction , 2011, Transfusion.

[66]  R. Colman,et al.  Generation of kinins during preparation and storage of whole blood–derived platelet concentrates , 2007, Transfusion.

[67]  M. Dupuis,et al.  Hypotensive reactions to red cells filtered at the bedside, but not to those filtered before storage, in patients taking ACE inhibitors , 1998, Transfusion.

[68]  P. Mintz,et al.  Posttransfusion purpura occurrence and potential risk factors among the inpatient US elderly, as recorded in large Medicare databases during 2011 through 2012 , 2015, Transfusion.

[69]  G. Pomper,et al.  A prospective, randomized, double‐blind controlled trial of acetaminophen and diphenhydramine pretransfusion medication versus placebo for the prevention of transfusion reactions , 2008, Transfusion.

[70]  E. Uhlmann,et al.  Successful treatment of recurrent hyperhemolysis syndrome with immunosuppression and plasma‐to‐red blood cell exchange transfusion , 2013, Transfusion.

[71]  R. Weiskopf,et al.  Transfusion-related acute lung injury: incidence and risk factors. , 2012, Blood.

[72]  N. Unni,et al.  Record fragmentation due to transfusion at multiple health care facilities: a risk factor for delayed hemolytic transfusion reactions , 2014, Transfusion.

[73]  B. Shaz,et al.  A comparison of adverse reaction rates for PAS C versus plasma platelet units , 2014, Transfusion.

[74]  S. Slichter,et al.  White blood cell inactivation after treatment with riboflavin and ultraviolet light , 2010, Transfusion.

[75]  R. Koshy,et al.  Anti-Kpa–induced severe delayed hemolytic transfusion reaction , 2009, Immunohematology.

[76]  H. Polesky,et al.  Iatrogenic Hemolysis: A Complication of Blood Warmed by a Microwave Device , 1972, Anesthesia and analgesia.

[77]  J. Steingrub,et al.  Hemotherapy bedside biovigilance involving vital sign values and characteristics of patients with suspected transfusion reactions associated with fluid challenges: can some cases of transfusion‐associated circulatory overload have proinflammatory aspects? , 2012, Transfusion.

[78]  W. Watson,et al.  The Therapeutic Value of HPA‐1a‐Negative Platelet Transfusion in Post‐Transfusion Purpura Complicated by Life‐Threatening Haemorrhage , 1995, Vox sanguinis.

[79]  M. Brecher,et al.  Atypical reactions associated with use of angiotensin‐converting enzyme inhibitors and apheresis , 1994, Transfusion.

[80]  M. Helmrath,et al.  Platelet Transfusions in Infants with Necrotizing Enterocolitis Do Not Lower Mortality but May Increase Morbidity , 2005, Journal of Perinatology.

[81]  J. Callum,et al.  A retrospective review of patient factors, transfusion practices, and outcomes in patients with transfusion-associated circulatory overload. , 2013, Transfusion medicine reviews.

[82]  P. Bitterman,et al.  Delayed hemolytic transfusion reaction presenting as sickle-cell crisis. , 1980, Annals of internal medicine.

[83]  G. Delage,et al.  Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection , 2011, Transfusion.

[84]  M. Murphy,et al.  The AABB recommendations for the Choosing Wisely campaign of the American Board of Internal Medicine , 2014, Transfusion.

[85]  Edmond Lee,et al.  Hyperhemolysis syndrome in sickle cell disease: case report (recurrent episode) and literature review , 2008, Transfusion.

[86]  J. Winters,et al.  The entity of immunoglobulin A–related anaphylactic transfusion reactions is not evidence based , 2015, Transfusion.

[87]  B. Dhingra,et al.  Alloimmunisation in thalassaemics: a comparison between recipients of usual matched and partial better matched blood. An evaluation at a tertiary care centre in India. , 2014, Blood transfusion = Trasfusione del sangue.

[88]  K. Sihler,et al.  Complications of massive transfusion. , 2010, Chest.

[89]  M. Jacobs,et al.  Detection of bacterial contamination in prestorage culture‐negative apheresis platelets on day of issue with the Pan Genera Detection test , 2011, Transfusion.

[90]  R. Weiskopf,et al.  Extracellular potassium concentrations in red blood cell suspensions after irradiation and washing , 2005, Transfusion.

[91]  F. Noizat‐Pirenne,et al.  Delayed hemolytic transfusion reaction in children with sickle cell disease , 2011, Haematologica.

[92]  R. Kalish,et al.  Post‐Transfusion Purpura: Initiation by Leukocyte‐Poor Red Cells in a Polytransfused Woman , 1987, Vox sanguinis.

[93]  M. Kuehnert,et al.  Transfusion‐related adverse reactions reported to the National Healthcare Safety Network Hemovigilance Module, United States, 2010 to 2012 , 2015, Transfusion.

[94]  W. Murphy,et al.  Testing platelet components for bacterial contamination. , 2011, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

[95]  A. Jayarajan,et al.  Post-transfusion purpura. , 2002, The Journal of the Association of Physicians of India.

[96]  H. Haak,et al.  RBC antibody persistence , 2000, Transfusion.

[97]  F. Noizat‐Pirenne.  Relevance of blood groups in transfusion of sickle cell disease patients. , 2013, Comptes rendus biologies.

[98]  S. Garza Salinas,et al.  [Prevention of allergic diseases]. , 1969, Alergia.

[99]  C. Parshuram,et al.  Transfusion-associated graft versus host disease , 2002, Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

[100]  H. Chandler.  Database , 1985 .

[101]  H. Yasuda,et al.  Risk of transfusion‐associated graft‐versus‐host disease as a result of directed donations from relatives , 1992, Transfusion.

[102]  V. Deneys,et al.  RECOMMENDATIONS IN THE EVENT OF A SUSPECTED TRANSFUSION-RELATED ACUTE LUNG INJURY (TRALI) , 2012, Acta clinica Belgica.

[103]  I. Shulman,et al.  Compatibility of ADSOL-stored red cells with intravenous solutions. , 1989, American Journal of Emergency Medicine.

[104]  R. Strauss.  Red blood cell storage and avoiding hyperkalemia from transfusions to neonates and infants , 2010 .

[105]  J. Rouleau,et al.  Bradykinin metabolism and hypotensive transfusion reactions , 2001, Transfusion.

[106]  J. S. Avalos,et al.  High‐Dose Intravenous Immunoglobulin in Non‐ABO Transfusion Incompatibility , 1994, Vox sanguinis.

[107]  A. Marti-Carvajal,et al.  Pharmacological interventions for the prevention of allergic and febrile non-haemolytic transfusion reactions. , 2010, The Cochrane database of systematic reviews.

[108]  R. Nuss,et al.  Extended red blood cell antigen matching for transfusions in sickle cell disease: a review of a 14‐year experience from a single center (CME) , 2011, Transfusion.

[109]  A. Sheikh,et al.  World Allergy Organization anaphylaxis guidelines: summary. , 2011, The Journal of allergy and clinical immunology.

[110]  F. Hirayama.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment , 2012, British journal of haematology.

[111]  Carol Stocks,et al.  Most Frequent Procedures Performed in U.S. Hospitals, 2011 , 2006 .

[112]  K. Thorpe,et al.  A randomized controlled trial comparing the frequency of acute reactions to plasma‐removed platelets and prestorage WBC‐reduced platelets , 2002, Transfusion.

[113]  D. Sayah,et al.  Transfusion reactions: newer concepts on the pathophysiology, incidence, treatment, and prevention of transfusion-related acute lung injury. , 2012, Critical care clinics.

[114]  M. Popovsky,et al.  How we view and approach transfusion‐associated circulatory overload: pathogenesis, diagnosis, management, mitigation, and prevention , 2013, Transfusion.

[115]  M. Friedlander,et al.  Meperidine to control shivering associated with platelet transfusion reaction , 1989, Canadian journal of anaesthesia = Journal canadien d'anesthesie.

[116]  J. Menitove,et al.  Regional registry of patient alloantibodies: first‐year experience , 2010, Transfusion.

[117]  J. McCullough,et al.  Using lean techniques to define the platelet (PLT) transfusion process and cost‐effectiveness to evaluate PLT dose transfusion strategies , 2012, Transfusion.

[118]  Frank Saran,et al.  Guidelines on the use of irradiated blood components prepared by the British Committee for Standards in Haematology blood transfusion task force , 2011, British journal of haematology.